Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06843278 · ClinicalTrials.gov registry record
Donor Breast Milk and Serum Ferritin Levels in Very Preterm Infants
A clinical trial of Ferritin Levels in Very Preterm Infants, sponsored by AdventHealth.
- Completed
- Registry status
- 34
- Enrollment target
- 1
- Study location
NCT06843278: Completed study of Ferritin Levels in Very Preterm Infants, sponsored by AdventHealth.
NCT06843278 is a study of Ferritin Levels in Very Preterm Infants that has completed, run by AdventHealth. The registered enrollment target is 34 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06843278, a study of Ferritin Levels in Very Preterm Infants, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
This study compares the iron levels in very preterm infants receiving donor breast (DBM) milk to very preterm infants receiving maternal breast milk (MBM).
Primary Outcome
The average serum ferritin level (ng/ml) in very preterm infants receiving donor breast milk or maternal breast milk
Conditions Studied
Interventions
- OTHER maternal breast milk
- OTHER Donor breast milk
Study Locations (1)
Florida
- AdventHealth - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2022-08-17 |
| Est. Completion | 2024-10-17 |
What the finished NCT06843278 record still lists
NCT06843278 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 1 condition, with Ferritin Levels in Very Preterm Infants appearing as the primary indexed condition, and to 2 interventions - of which maternal breast milk is the first listed.
NCT06843278 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06843278 about?
NCT06843278 is a clinical study titled "Donor Breast Milk and Serum Ferritin Levels in Very Preterm Infants". This study compares the iron levels in very preterm infants receiving donor breast (DBM) milk to very preterm infants receiving maternal breast milk (MBM).
What is the current status of trial NCT06843278?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2022-08-17. Estimated completion is 2024-10-17.
What conditions does trial NCT06843278 study?
This clinical trial studies the following conditions: Ferritin Levels in Very Preterm Infants.
What interventions are being tested in trial NCT06843278?
The interventions under investigation include: maternal breast milk (OTHER), Donor breast milk (OTHER).
Who is sponsoring clinical trial NCT06843278?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06843278 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI